Loading...
Cochlear Limited
CHEOY•PNK
HealthcareMedical - Devices
$88.18
$0.17(0.19%)
Cochlear Limited (CHEOY) Financial Performance & Statements
Review Cochlear Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
15.47%
↑ 15.47%
Operating Income Growth
26.45%
↑ 26.45%
Net Income Growth
18.70%
↑ 18.70%
Operating Cash Flow Growth
7.28%
↑ 7.28%
Operating Margin
21.70%
↑ 21.70%
Gross Margin
75.02%
↑ 75.02%
Net Profit Margin
15.85%
↑ 15.85%
ROE
19.70%
↑ 19.70%
ROIC
23.11%
↑ 23.11%
Cochlear Limited (CHEOY) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cochlear Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.14B | $1.11B | $1.06B | $892.60M |
| Cost of Revenue | $276.30M | $285.80M | $261.10M | $226.90M |
| Gross Profit | $868.50M | $827.60M | $802.00M | $665.70M |
| Gross Profit Ratio | $0.76 | $0.74 | $0.75 | $0.75 |
| R&D Expenses | $149.70M | $127.30M | $142.30M | $102.60M |
| SG&A Expenses | $465.60M | $432.00M | $441.50M | $368.90M |
| Operating Expenses | $615.30M | $559.30M | $583.80M | $471.50M |
| Total Costs & Expenses | $891.60M | $845.10M | $844.90M | $698.40M |
| Interest Income | $0.00 | $9.40M | $9.80M | $6.70M |
| Interest Expense | $0.00 | $4.30M | $4.70M | $4.70M |
| Depreciation & Amortization | $41.80M | $43.10M | $43.60M | $37.30M |
| EBITDA | $271.70M | $307.80M | $261.80M | $231.50M |
| EBITDA Ratio | $0.24 | $0.28 | $0.25 | $0.26 |
| Operating Income | $253.20M | $268.30M | $218.20M | $194.20M |
| Operating Income Ratio | $0.22 | $0.24 | $0.21 | $0.22 |
| Other Income/Expenses (Net) | -$28.20M | -$7.90M | -$9.10M | -$6.50M |
| Income Before Tax | $225.00M | $260.40M | $209.10M | $187.70M |
| Income Before Tax Ratio | $0.20 | $0.23 | $0.20 | $0.21 |
| Income Tax Expense | $59.40M | $68.60M | $49.90M | $46.10M |
| Net Income | $165.40M | $191.40M | $159.00M | $141.60M |
| Net Income Ratio | $0.14 | $0.17 | $0.15 | $0.16 |
| EPS | $2.53 | $2.92 | $2.42 | $2.15 |
| Diluted EPS | $2.52 | $2.91 | $2.41 | $2.15 |
| Weighted Avg Shares Outstanding | $65.49M | $65.58M | $65.67M | $65.78M |
| Weighted Avg Shares Outstanding (Diluted) | $65.74M | $65.71M | $66.002M | $65.78M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan